Independent directory Public ClinicalTrials.gov records United States
Clinical Trials Finder
Objective public record navigation
ClinicalTrials.gov record
Terminated Phase 2 Interventional

A Dose-Ranging Study of ATI 7505 in Patients With Postprandial Distress Syndrome

ClinicalTrials.gov ID: NCT00630370

Public ClinicalTrials.gov record NCT00630370. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search
ClinicalTrials.gov public records Last synced Jul 22, 2026, 4:51 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II, Randomized, Adaptive Design, Multicenter, Parallel Group, Placebo-Controlled, 58 Day, Dose-Ranging Study of ATI 7505 in Patients With Postprandial Distress Syndrome

Study identification

NCT ID
NCT00630370
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Procter and Gamble
Industry
Enrollment
6 participants

Conditions and interventions

Interventions

  • Placebo Drug
  • 20 mg ATI 7505 Drug
  • 40 mg ATI 7505 Drug
  • 80 mg ATI 7505 Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2008
Primary completion
Jun 30, 2008
Completion
Jun 30, 2008
Last update posted
Jun 16, 2009

2008

United States locations

U.S. sites
44
U.S. states
21
U.S. cities
40
Facility City State ZIP Site status
Research Facility Chino California 91710 —
Research Facility Fresno California 93721 —
Research Facility Los Angeles California 90015 —
Research Facility Los Angeles California 90045 —
Research Facility Mission Viejo California 92691 —
Research Facility San Carlos California 94070 —
Research Facility San Diego California 92108 —
Research Facility Littleton Colorado 80120 —
Research Facility Boynton Beach Florida 33426 —
Research Facility DeLand Florida 32720 —
Research Facility Hollywood Florida 33021 —
Research Facility Jacksonville Florida 32256 —
Research Facility Largo Florida 33777 —
Research Facility Miami Florida 33156 —
Research Facility New Port Richey Florida 34652 —
Research Facility Orlando Florida 32806 —
Research Facility Newnan Georgia 30263 —
Research Facility Savannah Georgia 31405 —
Research Facility Rockford Illinois 61107 —
Research Facility Evansville Indiana 47714 —
Research Facility Topeka Kansas 66606 —
Research Facility Monroe Louisiana 71201 —
Research Facility Detroit Michigan 48235 —
Research Facility Brooklyn New York 11214 —
Research Facility Great Neck New York 11021 —
Research Facility Great Neck New York 11023 —
Research Facility Lake Success New York 11042 —
Research Facility Syracuse New York 13210 —
Research Facility Fayetteville North Carolina 28304 —
Research Facility Winston-Salem North Carolina 27103 —
Research Facility Cincinnati Ohio 45242 —
Research Facility Dayton Ohio 45440 —
Research Facility Oklahoma City Oklahoma 73104 —
Research Facility Oklahoma City Oklahoma 73112 —
Research Facility Ashland Oregon 97520 —
Research Facility Beaver Falls Pennsylvania 15010 —
Research Facility Anderson South Carolina 29621 —
Research Facility Charleston South Carolina 29414 —
Research Facility Chattanooga Tennessee 37403 —
Research Facility Chattanooga Tennessee 37404 —
Research Facility Colleyville Texas 76034 —
Research Facility Salt Lake City Utah 84124 —
Research Facility Winchester Virginia 22601 —
Research Facility Milwaukee Wisconsin 53209 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 20 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00630370, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 16, 2009 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00630370 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →